2010
DOI: 10.1016/s1099-4831(10)06805-7
|View full text |Cite
|
Sign up to set email alerts
|

Galanthamine Production by Leucojum aestivum Cultures In Vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
8
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 44 publications
0
8
0
Order By: Relevance
“…The low Amaryllidaceae alkaloid accumulation commonly observed in in vitro cultures of Leucojum aestivum [6,[9][10][11][12][13] was probably due to the fact that the level of the alkaloid biosynthesis is strongly influenced by cellular differentiation [10,[14][15][16]. In particular, enhanced synthesis of galanthamine accompanied development of somatic embryos [17].…”
Section: Introductionmentioning
confidence: 99%
“…The low Amaryllidaceae alkaloid accumulation commonly observed in in vitro cultures of Leucojum aestivum [6,[9][10][11][12][13] was probably due to the fact that the level of the alkaloid biosynthesis is strongly influenced by cellular differentiation [10,[14][15][16]. In particular, enhanced synthesis of galanthamine accompanied development of somatic embryos [17].…”
Section: Introductionmentioning
confidence: 99%
“…Among the biological factors, let's focus on the importance of cell differentiation [23,24]. According to Stanilova et al [25], galanthamine content in L. aestivum directly regenerated bulblets was 10 times greater than in L. aestivum callus-derived shoots (over 1 mg/g DW vs. 0.1 to 0.2 mg/g DW). According to the same team, genotype is another crucially important factor for the biosynthetic capacity of in vitro cultures [26].…”
mentioning
confidence: 99%
“…Combining the technologies of DNA barcoding and metabolomics has the potential to dramatically transform the fundamental definition of a plant as a traditional medicine or dietary supplement and assist in assuring safety, efficacy, and product consistency for patients. However, the situation is made more complex by the observation that individual clones of plants may display significant differences in concentration of a major medicinal metabolite, such as galanthamine, during a yearly growth cycle, even under controlled culture conditions . The same could be true for potential toxic metabolites.…”
Section: The Shift To Improve Traditional Medicine Quality Controlmentioning
confidence: 99%